Pichova I - Search Results

1

Subsite specificity of the proteinase from myeloblastosis associated virus.

Konvalinka J, Blaha I, Skrabana R, Sedlacek J, Pichova I, Kapralek F, Kostka V, Strop P. Konvalinka J, et al. Among authors: pichova i. FEBS Lett. 1991 Apr 22;282(1):73-6. doi: 10.1016/0014-5793(91)80447-b. FEBS Lett. 1991. PMID: 2026269 Free article.

2

An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase.

Konvalinka J, Horejsí M, Andreánsky M, Novek P, Pichová I, Bláha I, Fábry M, Sedlácek J, Foundling S, Strop P. Konvalinka J, et al. Among authors: pichova i. EMBO J. 1992 Mar;11(3):1141-4. doi: 10.1002/j.1460-2075.1992.tb05154.x. EMBO J. 1992. PMID: 1547777 Free PMC article.

3

Isolation, biochemical characterization and crystallization of the p15gag proteinase of myeloblastosis associated virus expressed in E. coli.

Pichová I, Strop P, Sedlácek J, Kaprálek F, Benes V, Trávnícek M, Pavlícková L, Soucek M, Kostka V, Foundling S. Pichová I, et al. Int J Biochem. 1992 Feb;24(2):235-42. doi: 10.1016/0020-711x(92)90252-v. Int J Biochem. 1992. PMID: 1733789

4

Protein-engineered proteinase of myeloblastosis associated virus, an enzyme of high activity and HIV-1 proteinase-like specificity.

Strop P, Horejsí M, Konvalinka J, Skrabana R, Velek J, Bláha I, Cerná V, Pichová I, Pavlícková L, Andreánsky M, et al. Strop P, et al. Among authors: pichova i. Adv Exp Med Biol. 1991;306:515-8. doi: 10.1007/978-1-4684-6012-4_68. Adv Exp Med Biol. 1991. PMID: 1812751 No abstract available.

5

Molecular characteristics of pepsinogen and pepsin from duck glandular stomach.

Pichová I, Kostka V. Pichová I, et al. Comp Biochem Physiol B. 1990;97(1):89-94. doi: 10.1016/0305-0491(90)90183-t. Comp Biochem Physiol B. 1990. PMID: 2253484

6

A modular approach to HIV-1 proteinase inhibitor design.

Uhlíková T, Konvalinka J, Pichová I, Soucek M, Kräusslich HG, Vondrásek J. Uhlíková T, et al. Among authors: pichova i. Biochem Biophys Res Commun. 1996 May 6;222(1):38-43. doi: 10.1006/bbrc.1996.0694. Biochem Biophys Res Commun. 1996. PMID: 8630071

7

Potency comparison of peptidomimetic inhibitors against HIV-1 and HIV-2 proteinases: design of equipotent lead compounds.

Weber J, Majer P, Litera J, Urban J, Soucek M, Vondrásek J, Konvalinka J, Novek P, Sedlácek J, Strop P, Kräusslich HG, Pichová I. Weber J, et al. Among authors: pichova i. Arch Biochem Biophys. 1997 May 1;341(1):62-9. doi: 10.1006/abbi.1997.9945. Arch Biochem Biophys. 1997. PMID: 9143353

8

Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.

Hrusková-Heidingsfeldová O, Bláha I, Urban J, Strop P, Pichová I. Hrusková-Heidingsfeldová O, et al. Among authors: pichova i. Leukemia. 1997 Apr;11 Suppl 3:45-6. Leukemia. 1997. PMID: 9209292

9

Peptide inhibitors of HIV-1 and HIV-2 proteases: a comparative study.

Pichová I, Weber J, Litera J, Konvalinka J, Vondrásek J, Soucek M, Strop P, Majer P, Heuser AM, Kraeusslich HG. Pichová I, et al. Leukemia. 1997 Apr;11 Suppl 3:120-2. Leukemia. 1997. PMID: 9209317

10

Configurations of diastereomeric hydroxyethylene isosteres strongly affect biological activities of a series of specific inhibitors of human-immunodeficiency-virus proteinase.

Konvalinka J, Litera J, Weber J, Vondrásek J, Hradílek M, Soucek M, Pichová I, Majer P, Strop P, Sedlácek J, Heuser AM, Kottler H, Kräusslich HG. Konvalinka J, et al. Among authors: pichova i. Eur J Biochem. 1997 Dec 1;250(2):559-66. doi: 10.1111/j.1432-1033.1997.0559a.x. Eur J Biochem. 1997. PMID: 9428710 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters